Arthroscopic Shoulder Surgery
Conditions
Interventions
Control group (pseudo-stimulation):Percutaneous stimulation of the ear vagus nerve
Observation group (real stimulus):Percutaneous vagus nerve stimulation
Sponsors
Hangzhou Third People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Adults, regardless of gender; 2. ASA grade I - II; 3. Patients scheduled for arthroscopic shoulder surgery.
Exclusion criteria
Exclusion criteria: 1:Those with implanted devices in their bodies (such as pacemakers, implantable defibrillators, cochlear implants, deep brain stimulators, etc.) 2: Abnormalities or disorders in the left ear structure or function, or skin infections 3: Individuals with severe mental disorders 4: Opioid drug abusers 5: Those with abnormal liver and kidney functions 6: Patients allergic to anesthetic and analgesic drugs 7: Unable to cooperate with the research evaluators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total dosage of sufentanil within 24 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total dosage of remifentanil used during the operation;VAS;The number of patients receiving rescue analgesia; | — |
Countries
China
Contacts
Public ContactWang Bo
Hangzhou Third People’s Hospital
Outcome results
None listed